Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc.

NUS
Nu Skin Enterprises, Inc.US flagNew York Stock Exchange
5.60
USD
-0.03
- -
271.88MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
54.2
43.5
38.74
39.84
43.16
48.56
43.6
49.37
53.71
44.51
39.61
34.88
30.13
29.47
Basic EPS, GAAP
6.23
3.2
2.29
2.58
2.45
2.21
3.13
3.66
2.93
2.1
0.17
-2.95
3.25
1.11
Free Cash Flow per Basic Share
5.89
-2.67
4.58
4.06
4.59
2.4
2.01
6.03
1.45
0.98
1.21
1.41
0.93
0.85
Dividend per Share
1.2
1.38
1.4
1.42
1.44
1.46
1.48
1.5
1.52
1.54
1.56
0.24
0.24
0.24
Book Value per Share
22.77
24.41
25.76
28.13
30.47
29.65
31.12
35.2
38.09
38.79
37.63
34.47
37.74
38.02
Tangible Book Value per Share
11.31
12.78
11.14
8.76
9.89
8.98
10.78
11.51
12.54
12.48
10.23
9.94
13.77
13.72
Basic Weighted Avg Shares
59
59
58
55
53
55
56
52
50
50
50
50
49
49
Sales/Revenue/Turnover
3,177
2,569
2,247
2,208
2,279
2,679
2,420
2,582
2,696
2,226
1,969
1,732
1,485
1,441
Operating Margin (%)
17.44
13.71
10.89
10.47
12.04
11.63
11.05
9.98
10.6
7.16
3.46
2.93
6.12
5.66
Depreciation Expense
35
55
71
72
72
83
77
74
76
73
71
70
52
50
Net Income, GAAP
365
189
133
143
129
122
174
191
147
105
9
-147
160
55
Effective Tax Rate (%)
34.48
36.63
37.23
32.77
51.26
44.51
31.99
25.32
36.65
- -
67.66
- -
18.35
15.06
Profit Margin (%)
11.49
7.36
5.92
6.48
5.68
4.55
7.17
7.41
5.46
4.71
0.44
-8.46
10.79
3.78
Working Capital
342
416
299
315
330
360
383
360
343
401
373
242
284
266
LT Debt
114
165
182
334
311
361
440
425
363
466
558
430
268
258
Total Equity
859
942
826
664
705
782
875
894
913
897
822
651
805
794
Return on Invested Capital (%)
37.08
18.82
13.17
13.97
11.82
14.35
13.63
13.43
12.48
- -
1.52
- -
6.43
6.51
Return on Capital (%)
26.54
11.8
7.75
7.69
6.52
6
8.07
8.36
6.19
- -
0.68
- -
7.88
3.16
Return on Common Equity (%)
30.74
13.63
9.06
9.37
8.17
7.51
10.32
10.72
7.85
5.44
0.45
-8.18
8.97
2.97

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
20
38
20
LT Borrowings
209
204
204
LT Finance Leases
62
64
54
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
49
48
49
Market Capitalization
604
474
356

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
548
548
523
Cash, Cash Equivalents & STI
253
240
200
Accounts Receivable, Net
49
40
45
Inventories
179
179
179
Total Current Liabilities
254
264
257
Payables & Accruals
234
207
237
ST Debt
20
38
20
Deferred Revenue
- -
13
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.65%
-1.03%
23.61%
Free Cash Flow
0.87%
-20.95%
-34.42%
Net Income, GAAP
-211.37%
-431.71%
-209.28%
Sales/Revenue/Turnover
-3.48%
-10.17%
-14.26%
Total Cash Common Dividend
-8.95%
-17.27%
-0.78%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
417
439
430
446
1,732
2025
364
386
364
370
1,485
2026
321
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
-2.38
0.17
-0.73
-2.95
2025
2.16
0.43
0.35
0.3
3.25
2026
0.04
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.06
0.06
0.06
0.06
0.24
2025
0.06
0.06
0.06
0.06
0.24
2026
0.06
- -
- -
- -
- -

Company Description

APIChat
CEO
Ryan S. Napierski
Full Time Employees
3,100
Sector
Consumer Defensive
Industry
Household & Personal Products
Address
75 West Center Street Provo UT United States of America 84601
IPO Date
Nov 22, 1996
Website
nuskin.com
Business
Nu Skin Enterprises, Inc. (NYSE: NUS) is a global direct-selling company that develops, manufactures, and markets beauty, personal care, and nutritional supplements through a network of approximately 1.2 million independent distributors in 54 markets worldwide, including the Americas, Asia-Pacific, and Europe, the Middle East, and Africa. Founded in 1984 and headquartered in Provo, Utah, the company operates under the Nu Skin and Pharmanex brands, offering anti-aging skincare such as ageLOC series including Tru Face, LumiSpa, and LumiSpa iO; beauty devices like RenuSpa iO, an FDA-cleared microcurrent body device, Facial Spa, Galvanic Spa, and GloPRO Microneedling Tool; cosmetics and hair care products including Nu Colour Lash + Brow; Nutricentials Bioadaptive Skin Care; targeted wellness supplements like LifePak multivitamins, Nu Biome for gut health, and MYND360 for cognitive support with sleep, focus, and stress management formulas; oral care, body care, facial cleansers, moisturizers, and weight management solutions such as TR90; Epoch natural-ingredient products; and emerging connected devices under the IO platform including the upcoming Prysm iO intelligent beauty and wellness system. Recent developments include the January 2025 sale by its Rhyz Inc. subsidiary of the Mavely affiliate marketing platform to Later for approximately $250 million in cash and equity; the October 2024 launch of MYND360 cognitive health line following five years of research; the February 2024 introduction of RenuSpa iO as its first integrated beauty and wellness device; a June 2025 relaunch of ageLOC Tru Face with sustainable packaging; the June 2025 appointment of James Winett to its board; and strategic priorities for 2025 emphasizing core business strengthening, IO platform acceleration including RISE, and developing markets expansion such as into India, alongside recognition as the world's top beauty and wellness device systems company by Euromonitor for 2025.

Company News

APIChat
  • 5 Bargain Low Price-to-Sales Stocks Positioned to Deliver Solid Gains

  • 5 Value Stocks Trading at Attractive Price-to-Sales Ratios

  • 3 Cosmetics Stocks Gaining From AI, Wellness and Innovation Trends

  • Nu Skin Reaches 900 Million Meals Purchased and Donated in its Global Fight for Child Nutrition

  • Nu Skin Enterprises Q1 Earnings Call Highlights

  • Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 1Q26

  • Nu Skin Enterprises, Inc. (NUS) Q1 2026 Earnings Call Transcript

  • Nu Skin Enterprises (NUS) Q1 Earnings and Revenues Lag Estimates

  • Nu Skin Enterprises Reports First Quarter Results

  • Nu Skin Enterprises Announces Quarterly Dividend

  • Buy 14 Ideal Graham Value All-Stars Of 27 'Safer' Dividends In 71 April/May GVAS

  • Nu Skin Enterprises to Announce First Quarter 2026 Financial Results

  • Nu Skin Launches Prysm iO™: A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness

  • 71 April Graham Value All-Stars (GVAS): 14 To Buy

  • CWA Asset Management Group LLC Takes Position in Nu Skin Enterprises, Inc. $NUS

  • Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer

  • 14 Ideal 'Safer' Dividend Buys From 70 Mid-March Graham Value All-Stars (GVAS)

  • Nu Skin Appoints Chayce Clark as COO

  • 14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

  • Nu Skin: Patience Is Still Advised